|  |  | 

India Top Headlines

Officials to Discuss Xi’s Cooperation Offer with India to Develop Covid-19 Vaccine: China | India News


BEIJING: Officials from China and India will discuss cooperation modalities to develop the Covid-19 vaccine that was proposed by President Xi Jinping during the Brics summit, China’s Foreign Ministry said on Wednesday.
In his speech at the 12th Brics summit, Xi said on Tuesday that Chinese companies are working with their Russian and Brazilian partners on phase three of vaccine clinical trials.
“We are prepared to have cooperation with South Africa and India as well,” he said at the virtual summit, organized by Russian President Vladimir Putin and attended by Prime Minister Narendra Modi, Brazilian President Jair Bolsonaro and South African President Cyril Ramaphosa.
“China has joined the COVAX facility and will actively consider providing vaccines to Brics countries where necessary,” Xi said.
When asked what kind of cooperation China is seeking with India in vaccine development, Chinese Foreign Ministry spokesman Zhao Lijian told a news conference that “China will work to ensure the affordability and accessibility of vaccines. for developing countries “.
“We will continue to cooperate with all countries to promote our vaccine cooperation to achieve victory over the virus at an early date. Regarding the details, the competent authorities will have further discussions and communications with their counterparts on this issue,” he said.
The World Health Organization (WHO) has said that nine candidate vaccines, including two from China, are currently being evaluated for inclusion in the COVAX facility. COVAX is co-chaired by Gavi, an international vaccine alliance, the Coalition for Epidemic Preparedness Innovations (CEPI) and the WHO. Its objective is to accelerate the development and manufacture of vaccines.
China has pledged in more than a dozen countries, including Brazil, to carry out end-stage testing of experimental Covid-19 vaccines made in China and even started vaccinating thousands of its emergency workers, according to media reports. officers here.
Yang Sheng, deputy director of the drug registration office of the National Medical Products Administration, recently said that four Covid-19 vaccines developed in China have started the final stage of overseas human trials after obtaining approval from the authorities. foreign.
China has focused on developing five types of vaccines, with each method having at least one incoming clinical trial. In all, 11 vaccine candidates are in different stages of testing, Yang said.
So far, the coronavirus, which originated in the Chinese city of Wuhan, has infected more than 54 million people worldwide and killed more than 1.3 million more.

Times of India